Aethlon Medical Announces Contract with NAMSA to Advance Hemopurifier Clinical Programs in Cancer

SAN DIEGO, Jan. 30, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today announced that it has entered into an agreement with NAMSA, a world leading MedTech Contract Research…

Click here to view original post